| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,497 | 33,993 | 32,661 | 29,615 | | Cost of Revenue | 6,164 | 6,859 | 7,183 | 7,503 | | | Gross Profit |
-
| 27,134 | 25,478 | 22,112 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,431 | 15,778 | 14,605 | 14,605 | | Non Recurring |
-
| (672) | 672 |
-
| | Others | 6,859 | 5,804 | 3,200 | 3,695 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 6,224 | 7,001 | 3,812 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,043 | 6,224 | 7,001 | 3,812 | | Interest Expense | 1,751 | 1,784 | 1,902 | 2,449 | | Income Before Tax | 292 | 4,440 | 5,099 | 1,363 | | Income Tax Expense | (37) | 1,539 | 1,691 | 482 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 329 | 2,901 | 3,408 | 881 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 329 | 2,901 | 3,408 | 881 | | Preferred Stock And Other Adjustments | (513) | (507) | (501) | (145) | | | Net Income Applicable To Common Shares | ($184) | $2,394 | $2,907 | $736 |
|
0.51% Nasdaq 
0.26 (2.31%) 
Income Statement
